GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carilex Medical Inc (ROCO:7726) » Definitions » EV-to-Revenue

Carilex Medical (ROCO:7726) EV-to-Revenue : 1.82 (As of Jun. 03, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Carilex Medical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Carilex Medical's enterprise value is NT$641.3 Mil. Carilex Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was NT$351.7 Mil. Therefore, Carilex Medical's EV-to-Revenue for today is 1.82.

The historical rank and industry rank for Carilex Medical's EV-to-Revenue or its related term are showing as below:

ROCO:7726' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.14   Med: 1.97   Max: 2.45
Current: 1.82

During the past 5 years, the highest EV-to-Revenue of Carilex Medical was 2.45. The lowest was 1.14. And the median was 1.97.

ROCO:7726's EV-to-Revenue is ranked better than
66.14% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.09 vs ROCO:7726: 1.82

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), Carilex Medical's stock price is NT$34.80. Carilex Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$17.19. Therefore, Carilex Medical's PS Ratio for today is 2.02.


Carilex Medical EV-to-Revenue Historical Data

The historical data trend for Carilex Medical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carilex Medical EV-to-Revenue Chart

Carilex Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
- - - - 2.41

Carilex Medical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial - - - - 2.41

Competitive Comparison of Carilex Medical's EV-to-Revenue

For the Medical Devices subindustry, Carilex Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carilex Medical's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carilex Medical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Carilex Medical's EV-to-Revenue falls into.


;
;

Carilex Medical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Carilex Medical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=641.348/351.72
=1.82

Carilex Medical's current Enterprise Value is NT$641.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Carilex Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was NT$351.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carilex Medical  (ROCO:7726) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Carilex Medical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=34.80/17.192
=2.02

Carilex Medical's share price for today is NT$34.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was NT$17.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carilex Medical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Carilex Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Carilex Medical Business Description

Traded in Other Exchanges
N/A
Address
No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.

Carilex Medical Headlines

No Headlines